首页> 外文OA文献 >Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease

【2h】

Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease

机译：不同国家/地区不同机构的促红细胞生成素剂量变化及其与耐药性的关系21世纪肾脏疾病合并症的管理：贫血和骨病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Greenwood Roger N.; Ronco Claudio; Gastaldon Fiorella; Brendolan Alessandra; Homel Peter; Usvyat Len; Bruno Lenore; Carter Mary; Levin Nathan W.;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance [J] . Roger N Greenwood, Claudio Ronco, Fiorella Gastaldon, Kidney international. . 2003,第S87期

机译：不同国家不同机构的促红细胞生成素剂量变化及其与耐药性的关系
2. Individualized drug dosing using RBF-Galerkin method: Case of anemia management in chronic kidney disease [J] . Mirinejad Hossein, Gaweda Adam E., Brier Michael E., Computer Methods and Programs in Biomedicine: An International Journal Devoted to the Development, Implementation and Exchange of Computing Methodology and Software Systems in Biomedical Research and Medical Practice . 2017,第期

机译：使用RBF-Galerkin方法的个性化药物给药：慢性肾病中贫血管理的情况
3. Adaptation and Implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" Guidelines for Evaluation and Management of Mineral and Bone Disorders in Chronic Kidney Disease for Practice in the Middle East Countries [J] . Mona Al Rukhaimi, Ali Al Sahow, Yousef Boobes, Saudi journal of kidney diseases and transplantation : . 2014,第1期

机译：适应和实施“肾脏病：改善全球成果（KDIGO）”评估和管理慢性肾脏病在中东国家的矿物质和骨疾病指南
4. Erythropoiesis-stimulating-agent Dose Optimization for Anemia Management in Chronic Kidney Disease using Recursive Constrained Modeling and Zone Model Predictive Control [C] . Jayson McAllister, Jinfeng Liu, Zukui Li, Annual American Control Conference . 2018

机译：递归约束模型和区域模型预测控制用于慢性肾脏病贫血管理的红细胞生成刺激剂剂量优化
5. Retrospective Analysis of Phase 3 Clinical Trial to Evaluate the Efficacy of Drug B in Anemia Secondary to Chronic Kidney Disease [D] . Pollard, Kellyn 2019

机译：第3期临床试验的回顾性分析，评价患有慢性肾病的贫血药物B的疗效
6. Individualized Drug Dosing using RBF-Galerkin Method: Case of Anemia Management in Chronic Kidney Disease [O] . Hossein Mirinejad, Adam E. Gaweda, Michael E. Brier, -1

机译：使用RBF-Galerkin方法进行个体化给药：慢性肾脏病的贫血管理案例
7. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease [O] . Blaustein Daniel A., Schwenk Michael H., Chattopadhyay Jyoti, 2003

机译：慢性肾脏病患者加速蔗糖铁给药方案的安全性和有效性21世纪肾脏疾病合并症的管理：贫血和骨病

Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease

著录项

相似文献

相关主题

期刊订阅